StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Dare Bioscience's price to book ratio was 24.2× on Jul 31, 2026, against 12.9× a year earlier. Over the last 5 years it ranged from 1.4× to 160.1×, with a median of 8.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202624.2×+14.8
2025Dec 31, 20259.4×−150.7
2024Oct 31, 2024160.1×+147.1
2023Jul 31, 202312.9×+10.3
2022Dec 30, 20222.6×−2.2
2021Dec 31, 20214.8×−83.4
2020Oct 30, 202088.2×+80.6
2019Dec 31, 20197.6×+6.7
2018Dec 31, 20180.8×+0.3
2017Dec 29, 20170.6×−0.6
2016Dec 30, 20161.2×−0.1
2015Dec 31, 20151.3×−1.1
2014Dec 31, 20142.4×–

More Dare Bioscience figures

See a number that looks wrong?